文献速递糖尿病

血红蛋白A1c与合并及不合并糖尿病的老年人死亡率:来自美国国家健康与营养调查(1988-2011)的结果

Hemoglobin A1c and Mortality in Older Adults With and Without Diabetes: Results From the National Health and Nutrition Examination Surveys (1988-2011).
PubMed 文献 · Diabetes Care · 2017-02-21

该研究分析了NHANES III(1988-1994)和连续NHANES(1999-2004)中≥65岁成人(n=7,333)及其截至2011年12月的死亡链接数据,采用Cox比例风险模型分别评估合并与不合并糖尿病者HbA1c与全因及特定原因死亡风险的关系。中位随访8.9年期间4,729例死亡,合并糖尿病且HbA1c>8.0%者全因死亡风险显著高于HbA1c<6.5%者,未诊断糖尿病且HbA1c>6.5%者全因死亡风险高于无糖尿病且HbA1c 5.0-5.6%者。

要点

  • 合并糖尿病且HbA1c 8.0-8.9%者全因死亡HR为1.6(95%CI 1.02, 2.6),≥9.0%者为1.8(95%CI 1.3, 2.6),趋势P<0.001。
  • 未诊断糖尿病且HbA1c>6.5%者全因死亡风险为无糖尿病且HbA1c 5.0-5.6%者的1.3倍(95%CI 1.03, 1.8)。
  • 作者认为更好的血糖控制对降低死亡率重要,但鉴于证据存在矛盾,老年糖尿病患者需根据人口学特征、糖尿病病程和现有合并症个体化设定血糖目标。

核心结论

  • 在老年糖尿病患者中,HbA1c>8.0%与全因及特定原因死亡风险增加相关。
  • 作者认为更好的血糖控制对降低死亡率重要,但鉴于证据存在矛盾,老年糖尿病患者需根据人口学特征、糖尿病病程和现有合并症个体化设定血糖目标。

研究设计与样本

  • 分析NHANES III(1988-1994)和连续NHANES(1999-2004)中≥65岁成人(n=7,333)及其截至2011年12月的死亡链接数据。
  • 采用Cox比例风险模型分别评估合并与不合并糖尿病者HbA1c与全因及特定原因(心血管疾病、癌症、非心血管/非癌症)死亡风险的关系。

主要发现

  • 中位随访8.9年期间4,729例死亡,其中心血管疾病1,262例、癌症850例、非心血管/非癌症2,617例。
  • 与合并糖尿病且HbA1c<6.5%者相比,HbA1c 8.0-8.9%者全因死亡HR为1.6(95%CI 1.02, 2.6),HbA1c≥9.0%者为1.8(95%CI 1.3, 2.6),趋势P<0.001。
  • 未诊断糖尿病且HbA1c>6.5%者全因死亡风险为无糖尿病且HbA1c 5.0-5.6%者的1.3倍(95%CI 1.03, 1.8)。

关键数值与推荐

  • 合并糖尿病且HbA1c 8.0-8.9%者全因死亡HR为1.6(95%CI 1.02, 2.6),HbA1c≥9.0%者为1.8(95%CI 1.3, 2.6),趋势P<0.001。
  • 未诊断糖尿病且HbA1c>6.5%者全因死亡风险为无糖尿病且HbA1c 5.0-5.6%者的1.3倍(95%CI 1.03, 1.8)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Hemoglobin A1c (HbA1c) level has been associated with increased mortality in middle-aged populations. The optimal intensity of glucose control in older adults with diabetes remains uncertain. We sought to estimate the risk of mortality by HbA1c levels among older adults with and without diabetes. RESEARCH DESIGN AND METHODS: We analyzed data from adults aged ≥65 years (n = 7,333) from the Third National Health and Nutrition Examination Survey (NHANES III) (1998-1994) and Continuous NHANES (1999-2004) and their linked mortality data (through December 2011). Cox proportional hazards models were used to examine the relationship of HbA1c with the risk of all-cause and cause-specific (cardiovascular disease [CVD], cancer, and non-CVD/noncancer) mortality, separately for adults with diabetes and without diabetes. RESULTS: Over a median follow-up of 8.9 years, 4,729 participants died (1,262 from CVD, 850 from cancer, and 2,617 from non-CVD/noncancer causes). Compared with those with diagnosed diabetes and an HbA1c <6.5%, the hazard ratio (HR) for all-cause mortality was significantly greater for adults with diabetes with an HbA1c >8.0%. HRs were 1.6 (95% CI 1.02, 2.6) and 1.8 (95% CI 1.3, 2.6) for HbA1c 8.0-8.9% and ≥9.0%, respectively (P for trend <0.001). Participants with undiagnosed diabetes and HbA1c >6.5% had a 1.3 (95% CI 1.03, 1.8) times greater risk of all-cause mortality compared with participants without diabetes and HbA1c 5.0-5.6%. CONCLUSIONS: An HbA1c >8.0% was associated with increased risk of all-cause and cause-specific mortality in older adults with diabetes. Our results support the idea that better glycemic control is important for reducing mortality; however, in light of the conflicting evidence base, there is also a need for individualized glycemic targets for older adults with diabetes depending on their demographics, duration of diabetes, and existing comorbidities.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Palta P, Huang ES, Kalyani RR, et al. Hemoglobin A1c and Mortality in Older Adults With and Without Diabetes: Results From the National Health and Nutrition Examination Surveys (1988-2011). Diabetes Care. 2017. PMID: 28223299. doi:10.2337/dci16-0042

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。